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Abstract
Introduction. The diverse social and cultural contexts may cause differences in perceiving symptoms of the 
chronic venous disease (ChVD), not only in global, European terms, but also in a regional context. The pur-
pose of the study was to find the regional differences of the reported symptoms and the applied conservative 
treatment methods among patients with ChVD diagnosed by the primary health care (PHC) doctors in Poland.
Material and methods. 13 393 patients participated in the multi-centre PHLEBOS-2 research carried 
out by 330 PHC doctors in 15 voivodeships.
Results. In the study group of patients, 31.9% of patients had ChVD symptoms – the C0 stage, telangiec-
tasias and venulectasias (C1 stage) occurred among 56.1% of patients, varices without symptoms of venous 
insufficiency occurred among 6% of patients and venous insufficiency among 6% of patients. Venous ulcers 
(active or healed) occurred among 0.6% of subjects. Essential differences in the ChVD structure between 
voivodeships were noted. 
Among the most frequently reported ChVD ailments were heaviness of legs (72.9%), ankle swelling in the eve-
nings (68.4%) and nighttime leg cramps (58.6%). Leg swelling during the night hours occurred less frequently 
— 39.8%, paraesthesias — 30.4%, restless legs syndrome — 18.6%. The average intensity of calf pain was 
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moderate (3.82 ± 1.86 points in the 10 point scale). The territorial diversity in the prevalence of symptoms 
was significant and resulted neither from the ChVD seriousness, nor from the age of the patients. 
Compression therapy was applied on average by 12.5% of patients and 24.8% of patients used phlebotropic 
drugs with large territorial variations (respectively from 3.4% to 28.8% and from 11.2 to 56.1%). The differences 
between the voivodeships were greater than the regional differences and did not depend on the ChVD stage.
Conclusions. There are significant territorial variations in Poland in the frequency of the reported symptoms 
and in the conservative therapy of the chronic venous disease.
Key words: chronic venous diseases, venous insufficiency, restless legs syndrome, varicose veins
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Introduction
It is estimated that about 63% of the world popula-
tion suffers from chronic venous disease (ChVD) of the 
lower extremities (C1–C6 stages) and 9.6% has symp-
toms of venous insufficiency C3 to C6 according to the 
CEAP (Clinical, Etiologic, Anatomic, Patophysiologic) 
classification [1]. However, venous ulcers occur among 
1–2% of patients [1, 2]. The epidemiological studies 
show a significant regional diversity of the morbidity 
rate [1, 2]. A milestone in the epidemiological studies 
was the systematization of the disease and its division 
into 7 stages in 1994 — the CEAP classification, which is 
commonly accepted in the updated version of 2004 [3].
The ChVD epidemiology in Poland was rarely 
investigated. The first significant study was carried 
out more than 10 years ago [4]. This study covered 
40 095 adult patients who contacted 803 family doctors 
and gynaecologists seeking help for any reason. On 
account of a significant participation of gynaecologists, 
the percentage of women participating in this study 
was as high as 84%. 51% of women and 38% of men 
had ChVD symptoms. Venous insufficiency (stage C3–6) 
was diagnosed among 10% of subjects and the past 
and active ulcers occurred among 1.5% of patients. 
Among the ChVD symptoms (stages C1–6) reported by 
the patients, the most frequently occurring were: pain 
(70% of men and 77% of women), heaviness of legs 
(67% of men and 75% of women), cramps (61% of 
men and 57% of women) and swelling (48% of men 
and 57% of women). Only 23% of patients with ChVD 
applied conservative treatment recommended to tackle 
this disease (phlebotropic drugs, compression therapy). 
Later, the epidemiological studies conducted in 
Poland analyzed the main aspects of treating patients 
suffering from ChVD, such as compression therapy and 
pharmacotherapy. It was ascertained that only 25.6% of 
the patients who were treated by primary health care 
doctors applied compression therapy, partly due to the 
fact that this form of therapy was not duly propagated 
by family doctors [5], as well as, due to rejecting it by 
a lot of patients because of high therapy costs (33.0%), 
sweating (27.3%), itchiness (13.6%), cosmetic reasons 
(13.6), edema intensification (6.8%), exudate (3.4%) 
and application difficulties (2.3%) [6]. The percentage 
of patients who do not approve of the compression 
therapy decreases with the progression of the disease to 
27.3%, in stage C6 according to CEAP classification [7]. 
In the era of aggressive TV, radio and newspaper 
advertisements, the most widespread treatment me-
thod among the patients with ChVD is pharmacotherapy, 
being often changed after seeing a consecutive adver-
tisement of “a significantly better” drug. Phlebotropic 
drugs are accepted by over 95% of patients entering 
ChVD treatment [7].
If the compression therapy is not applied regularly 
or it is discontinued, the disease progresses and the 
treatment costs incurred by the health care system 
increase. According to the data of NFZ (National 
Health Fund) 41–44 thousand vein surgeries of lower 
extremities were carried out annually in Poland in the 
years 2009–2013, most frequently saphenous veins 
were removed with the varicose veins. The NFZ data 
do not include all surgeries, especially those advanced 
ones which are still not reimbursed.
The perceptions of one’s own disease by patients 
is a complex process depending on the possessed 
knowledge and convictions as to its significance in view 
of their past life.
The individual features of people related to be-
haviour focused on the reduction of psychological 
stress and related to health measures determining the 
course of a given disease, have a significant impact on 
the mental condition, functioning of the patient. These 
features, as well as accessibility to medical services also 
determine actions taken by the patients, including such 
actions as obtaining medical aid and self-medication. 
More and more patients decide to start treatment after 
looking up information on the Internet and watching 
and reading advertisements in the mass media. 
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Different social and cultural variations may be 
caused by a different way of perceiving the ChVD 
symptoms not only in global, European terms, but also 
in a regional context. That is why the purpose of this 
study was to explore regional differences of the report-
ed symptoms and the applied methods of conservative 
treatment among patients with ChVD diagnosed by the 
primary health care (POZ) doctors in Poland.
Material and methods
The PHLEBOS-2 research was conducted by 330 pri - 
mary health care doctors in 15 out of 16 voivodeships. 
Patients with ChVD symptoms, who have not taken 
the phlebotropic drugs for at least 30 days and con-
sulted the physicians, were successively recruited to 
the PHLOBOS-2 research. The criteria which ruled 
out the participation in the PHLEBOS research were: 
pregnancy, decompensated heart defects, congestive 
heart failure, chronic obstructive pulmonary disorder 
(COPD), liver cirrhosis, advanced cancer, atheroscle-
rosis of lower extremities (with an ankle-brachial index 
/ABI/ of < 0.85), ulceration of the lower legs of a differ-
ent etiology, patients with a significant disability caused 
by the osteoarticular diseases or postictal states. For 
carrying out the research, the approval of the Bio ethics 
Committee of the Silesian Medical University was ob-
tained. Each patient gave his/her informed consent for 
taking part in the study.
The research protocol assumed the baseline as-
sessment of the disease progression in the CEAP scale 
(C0–C6), of the occurring symptoms and ailments (swell-
ing, heavy legs, night cramps, burning sensation and 
paraesthesias, restless legs syndrome, the assessment of 
calf pain intensity and the subjective assessment of the 
state of health in the VAS analog scale, measurements 
of circumferences of both lower limbs at an ankle level, 
½ of the leg length below the knee and 1/3 of the length 
of the lower part of the thigh.
The research project assumed the recruitment of 
16 thousand patients. After rejecting the incomplete 
protocols (n = 1 956), a group of 13 393 patients with 
ChVD was analyzed and furthermore 651 patients with 
C2 progression or a higher one were referred for further 
treatment in the Vascular Clinics.
Analysis of data
The analysis compares the ChVD progession in the 
CEAP scale, the frequency of the symptoms reported 
by the patients, the frequency of applying compression 
therapy in respective voivodeships in relation to average 
values for the entire study group (Poland) prior to the 
application of phlebotropic drugs.
Statistical analysis 
A statistical analysis was carried out using the STA-
TISTICA 10 PL programme.
Variable values were presented as average values 
with a standard deviation. The chi-square test was 
applied for comparing the prevalence of features and 
the Student’s t-test compared the difference between 
variances. The value of p < 0.05 was adopted as the 
value for statistical significance. 
Results
Profile of the study group 
Among 13 393 patients participating in the study, 
83.6% were living in cities and 16.4% in rural munici-
palities (Table 1). In comparison with the data of GUS 
(Main Statistical Office) 2012 (rural population 39.4%), 
there was an essential over-representation of the urban 
population in the trial population. Coexisting chronic 
diseases were reported among 33.4% of subjects. The 
symptoms of ischaemia of the lower extremities were 
reported by 12.0% of patients (claudication distance 
< 500 m — 10.2% and < 200m — 1.8%). 48.8% 
performed sedentary jobs and 37.2% of the subjects 
worked in a standing position. Significant variations 
between the voivodeships and even within the regions 
were ascertained (Table 2), amounting to 20% for those 
performing sedentary work and 15% for those working 
in a standing position. There was also diversity among 
the patients performing hard physical work.
Progression of the chronic venous disease
In the patient study group, 31.9% of patients only 
had ChVD symptoms — stage C0, 56.1% had telangiec-
tasias and venulectasias (stage C1), 6% had varices 
without symptoms of venous insufficiency and 6% 
suffered from venous insufficiency (Table 3). Active or 
healed venous ulcers occurred among 0.6% of subjects. 
Substantial differences in the ChVD structure were 
noted in some parts of the Podkarpackie, Podlaskie, 
Świętokrzyskie, Pomorskie and Warmińsko-Mazurskie 
Voivodeships. The lowest percentage of patients in stage 
C0 was reported in the Warmińsko-Mazurskie Voivode-
ship (6.6%), the Świętokrzyskie Voivodeship (15.1%) 
and the Podlaskie Voivodeship (19.1%), whereas, 
the highest percentage was noted in the Pomorskie 
Voivodeship (41.1%). The above compilation did not 
include data of patients with venous insufficiency in 
four provinces — the Podlaskie, Warmińsko-Mazurskie, 
Opolskie and Podkarpackie Voivodeships. However, 
the primary health care doctors in the Świętokrzyskie 
Voivodeship diagnosed venous insufficiency among as 
many as 45.7% of the subjects.
34
Acta Angiol, 2015, Vol. 21, No. 2
www.angiologia.pl
Symptoms of the chronic venous disease 
Among the most frequently reported ChVD ail-
ments were: heaviness of legs (72.9%), ankle swelling 
in the evenings (68.4%) and nighttime leg cramps 
(58.6%). The remaining symptoms occurred among less 
than half of the subjects (leg swelling during the evening 
hours — 39.8%, paraesthesias — 30.4%, restless legs 
syndrome — 18.6%). The average intensity of calf 
pain was moderate (3.82 ± 1.86 points in the 10 point 
scale; Table 4).
The prevalence of symptoms showed a substantial 
territorial diversity. Ankle swelling during the evening 
hours was more frequently reported by doctors from 
the Łódzkie Voivodeship and more seldomly by doc-
tors in the Śląskie, Podkarpackie and Kujawsko-Po-
morskie Voivodeships. Leg swelling during the evening 
hours was reported most seldomly in the Śląskie and 
Kujawsko-Pomorskie Voivodeships. As far as other 
cases than ankle swelling are concerned, there was 
a disproportionately high ratio of leg swelling record-
ed during the afternoon hours in other voivodeships 
(Małopolskie, Świętkorzyskie, Zachodniopomorskie, 
Opolskie and Warmińsko-Mazurskie). A big variability 
of frequency was noted for the recorded swellings. 
From merely 0.6–1.3% in the Warmińsko-Mazur-
skie Voivodeship to 70.7% in the Świętkorzyskie 
Voivodeship. The heaviness of legs rarely coincided 
with the prevalence of swellings. The convergence of 
symptoms was recorded for the Mazowieckie and Ku-
jawsko-Pomorskie Voivodeships. Disproportionately 
heaviness was reported by patients from the Lubel-
skie, Podlaskie, Warmińsko-Mazurskie and Pomorskie 
Voivodeships. No relation between the heaviness of 
legs and calf pain intensification was noted.
Nighttime leg cramps were reported by patients 
from the Podlaskie, Świętokrzyskie and Zachodnio-
pomorskie Voivodeships and more seldomly from the 
Opolskie and Warmińsko-Mazurskie Voivodeships. The 
prevalence of cramps was not linked to paraesthesia 
and the restless legs syndrome.
Table 1. Demographic characteristics of patients suffering from the chronic venous disease with the division into regions and 
voivodeships
Age (years) Place of residence (%)
Village Towns < 10  
thousand residents 
Cities 10–100  
thousand residents
Cities > 100  
thousand residents 
Poland [n = 13 393] 50 ± 14 16.4 8.8 24.9 49.9
Central Region
Łódzkie [n =1180] 52 ± 15 19.1 3.6 14.4 62.9
Mazowiecki [n = 1604] 51 ± 14 11.5 5.4 19.5 63.5
Southern Region
Małopolskie [n = 1021] 51 ± 14 41.9 11.8 11.6 34.6
Śląskie [n = 2238] 50 ± 13 4.3 5.0 32.2 58.5
Eastern Region
Lubelskie [n = 947] 48 ± 15 23.6 10.5 44.8 21.1
Podkarpackie [n = 441] 53 ± 12 39.8 32.7 27.2 0.2
Podlaskie [n = 382] 46 ± 13 6.6 10.3 12.4 70.7
Świętokrzyskie [n = 123] 58 ± 16 44.2 5.8 49.2 0.8
Western Region 
Wielkopolskie [n = 2014] 47 ± 14 15.4 15.7 30.3 38.7
Zachodniopomorskie [n = 480] 51 ± 13 8.8 6.6 33.3 51.3
South-western Region
Dolnośląskie [n = 828] 53 ± 13 12.8 5.7 12.8 68.6
Opolskie [n = 463] 53 ± 12 23.4 19.3 46.8 10.6
Northern Region
Kujawsko-Pomorskie [n = 734] 51 ± 15 4.5 1.3 2.5 91.7
Pomorskie [n = 778] 46 ± 14 13.0 3.9 32.6 50.5
Warmińsko-Mazurskie [n = 160] 57 ± 12 48.8 0 0 51.3
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These ailments showed big variations between 
the voivodeships, yet not between the regions 
(Table 4). 
Quality of life of patients with chronic  
venous disease 
The subjects perceived the quality of life in different 
regions and voivodeships in a similar way (Table 4). The 
lowest quality of life was reported by patients living in 
the Podlaskie Voivodeship and the highest quality of life 
was reported in the Kujawsko-Pomorskie Voivodeship. 
The quality of life in these voivodeships was related 
neither to the seriousness of ChVD, nor the age of 
the patients.
Application of compression therapy and phle-
botropic drugs by the patients in the past
The compression therapy was applied on average 
by 12.5% of patients. Among the frequently used 
compression products were knee socks (5.4%) and 
stockings/tights (5.2%) — Table 5. 
Bandages (2.1%) were more seldomly used by 
patients. The differences between voivodeships were 
greater than regional differences. Compression products 
were used most frequently by patients from Zachodnio-
pomorskie Voivodeship (28.8%) and most seldomly by 
patients from the Podlaskie and Świętokrzyskie Voivode-
ships (3.4 and 4.1% respectively). The frequency of using 
the compression products in respective voivodeships did 
not depend on the ChVD progession.
In the past only every fourth patient (n = 3272) took 
phlebotropic drugs and there was a large territorial 
diversity — from 11.2 to 56.1% (Table 5).
Discussion
The results of the conducted analysis indicate that 
the early stages of the chronic venous disease are dia-
Table 2. Analysis of the performed work by patients suffering from chronic venous disease with the division into regions and 
voivodeships
Place of residence (%) 
Sedentary work  
> 6 h/d
Work in a standing  
position > 6 h/d
Hard physical work  
> 6 h/d
Other
Poland [n =13 393] 48.8 37.2 10.7 3.4
Central Region
Łódzkie [n = 1180] 51.6 32.5* 13.7** 2.3*
Mazowieckie [n = 1604] 58.5^ 31.2** 7.9** 2.4*
Southern Region
Małopolskie [n = 1021] 48.0 34.2 15.3^ 2.5
Śląskie [n = 2238] 48.9 40.3 7.4^ 3.5
Eastern Region
Lubelskie [n = 947] 35.3^ 40.8 17.2^ 6.7^
Podkarpackie [n = 441] 55.1 32.6 9.8 2.6
Podlaskie [n = 382] 45.0 45.3* 6.8* 2.9
Świętokrzyskie [n = 123] 59.7 30.6 8.1 1.6
North-western Region
Wielkopolskie [n = 2014] 47.3 39.7 8.0^ 5.1^
Zachodniopomorskie [n = 480] 50.7 34.6 11.9 2.7
South-western Region
Dolnośląskie [n = 828] 50.1 36.4 10.2 3.3
Opolskie [n = 463] 46.1 36.2 16.7^ 1.1**
Northern Region 
Kujawsko-Pomorskie [n = 734] 42.5* 38.7 15.6^ 3.3
Pomorskie [n = 778] 48.6 40.2 8.9 2.4
Warmińsko-Mazurskie [n = 160] 51.2 44.6 3,3** 0.8
Statistical significance in relation to “Poland” c2 — *p < 0.05; **p < 0.01; ^p < 0.001
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Table 3. Progression of the chronic venous disease with division into regions and voivodeships 
C0 C1 C2 C3 C4 C5 C6
Poland [n = 13 393] 31.9% 56.1% 6.0% 4.0% 1.4% 0.4% 0.2%
Central Region
Łódzkie [n = 1180] 35.4% 55.4% 2.6%^ 5.0% 1.3% 0.2% 0.1%
Mazowieckie [n = 1604] 24.4%^ 57.9% 7.9%** 5.3%* 2.9%^ 0.7% 0.9%^
Southern Region
Małopolskie [n = 1021] 25.9%** 56.4% 7.4% 6.9%^ 2.7%^ 0.6% 0.1%
Śląskie [n = 2238] 37.2%** 56.5% 3.1%^ 2.7%** 0.3%^ 0.1%* 0.1%
Eastern Region
Lubelskie [n = 947] 33.8% 58.3% 2.8%^ 1.7%^ 1.2% 0.9%* 0.3%
Podkarpackie [n = 441] 51.9%^ 46.3%* 1.8%^ 0^ 0* 0 0
Podlaskie [n = 382] 19.1%^ 80.9%^ 0^ 0^ 0* 0 0
Świętokrzyskie [n = 123] 15.1%** 14.4%^ 23.8%^ 30.2%^ 9.0%^ 5.7%^ 0.8%
North-western Region
Wielkopolskie [n = 2014] 30.1% 53.9% 10.0%^ 3.4% 1.3% 0.2% 0.1%
Zachodniopomorskie [n = 480] 32.2% 57.5% 7.9% 3.2% 0.2%* 0 0
South-western Region
Dolnośląskie [n = 828] 20.5%^ 65.8%** 6.1% 6.0%** 1.0% 0.6% 0
Opolskie [n = 463] 35.3% 64.4% 0.3%^ 0^ 0* 0 0
Northern Region 
Kujawsko-Pomorskie [n = 734] 39.2%** 54.1% 1.8%^ 2.0%** 1.9% 0.7% 0.3%
Pomorskie [n = 778] 41.1%^ 31.6%^ 16.3%^ 8.4%^ 2.6%** 0 0
Warmińsko-Mazurskie [n = 160] 6.6%^ 92.7%^ 0.7%** 0* 0 0 0
Statistical significance in relation to “Poland” c2 — *p < 0.05; **p < 0.01; ^p < 0.001
gnosed in Poland more and more often. In view of the 
ongoing changes, the percentage of patients with ve-
nous insufficiency decreases. This percentage decreased 
from 10% at the turn of the century [4] to 6%, as this 
research shows. Currently, ChVD is diagnosed in every 
third patient (31.9%) merely on the basis of ailments 
with no telangiectasias, venulectasias, varices and 
skin lesions (stage Co). This percentage is higher than 
the one indicated by Beebe-Dimmer and colleagues 
(23.6% — after recounting for ChVD patients) [1]. 
Patients in stage C1 — 56.1% constituted the biggest 
group of patients. However,(active or healed) venous 
ulcers occurred among 0.6% of subjects not taking 
phlebotropic drugs on a regular basis, over two times 
less than in the research carried out by Jawień and 
colleagues (1.5%) [4]. The prevalence of the ChVD 
stages essentially deviated from the one indicated by 
Beebe-Dimmer and colleagues [1]: stage C1 — 26.0%, 
C2 — 17.9%, C3–C6 — 29.1% (values recounted for 
the ChVD patients). 
The patients with stages C2–C6 (12%) were con-
siderably less involved in the presented research. The 
main reason for this were most probably the inclusion 
criteria for the participation in this study — exclusion 
of patients taking phlebotropic drugs on a regular basis. 
The prevalence of the ChVD stages differed essentially 
in respective voivodeships. Significant diversity, even within 
the regions, points rather to essential variations of applied 
diagnostic criteria as a consequence of an insufficient 
awareness of the international CEAP classification. This 
is caused by the marginalization of ChVD in the training 
programmes of family doctors and internists in the past 
and a relatively weak dissemination of scale among doctors 
who are not engaged in treating vascular diseases.
The most frequently reported symptoms and ail-
ments of ChVD are: heaviness of legs (72.9%), ankle 
swelling during the evening hours (68.4%) and night-
time leg cramps (58.6%).
Symptoms which occurred less frequently in the 
study group of patients were leg swelling during evening 
hours — 39.8%, paraesthesias — 30.4%, restless legs 
syndrome — 18.6%. It should be emphasized that the 
prevalence of the symptoms showed significant territo-
rial diversity which resulted neither from the differences 
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Table 5. Frequency of applying compression therapy and phebotropic drugs by patients suffering from chronic venous disease 
with division into regions and voivodeships 
Compression therapy (%) Phlebotropic drugs  
in the past (%)In total Stockings/tights Knee socks Bandages
Poland [n = 13 393] 12.5 5.2 5.4 2.1 24.7
Central Region
Łódzkie [n = 1180] 10.2* 3.8* 4.2 2.2 28.6*
Mazowieckie [n = 1604] 16.5^ 6.5* 8.2^ 1.8 31.7^
Southern Region
Małopolskie [n = 1021] 20.0^ 7.9^ 10.0^ 2.1 35.1^
Śląskie [n = 2238] 9.4^ 4.0* 3.8** 1.6 19.6^
Eastern Region
Lubelskie [n = 947] 20.3^ 9.9^ 7.7** 2.7 36.6^
Podkarpackie [n = 441] 20.2^ 12.9^ 5.4 1.9 29.5
Podlaskie [n = 382] 3.4^ 0^ 3.4 0** 14.4^
Świętokrzyskie [n = 123] 4.1^ 1.7 0.8* 1.6 56.1^
North-western Region
Wielkopolskie [n = 2014] 9.0^ 4.0* 3.1^ 1.9 19.4^
Zachodniopomorskie [n = 480] 28.8^ 11.0^ 11.9^ 5.9^ 11.2^
South-western Region
Dolnośląskie [n = 828] 9.3* 3.7 2.5^ 3.1 23.7
Opolskie [n = 463] 14.3 6.1 6.5 1.7 23.1
Northern Region 
Kujawsko-Pomorskie [n = 734] 8.0** 4.8 2.2^ 1.0* 20.0*
Pomorskie [n = 778] 8.0^ 0.9^ 4.8 2.3 12.6^
Warmińsko-Mazurskie [n = 160] 8.8 1.3* 5.0 2.5 21.9
Statistical significance in relation to „Poland” c2 — *p < 0.05; **p < 0.01; ^p < 0.001
in the ChVD intensity, nor the age of the patients. Also 
in this case, a considerable diversity of the frequency 
of symptoms between voivodeships belonging to the 
regions implies rather variations in collecting detailed 
survey data by respective doctors, resulting from 
professional experience. Such an interpretation is also 
backed up by a significant percentage of patients (12%) 
with symptoms of lower limb atherosclerosis, despite 
the fact that they have been placed in the exclusion 
criteria of the ankle-brachial index (ABI < 0.85).
In the study group every fourth patient took phlebo-
tropic drugs in the past and 12.5% of patients applied 
compression therapy. These values cannot be applied 
to the frequency of applying treatment methods among 
patients with the diagnosed ChVD, because in some 
patients this disease entity was not diagnosed earlier. 
Attention should be drawn to the structure of the used 
compression products. Knee socks and stockings/tights 
were used with the same prevalence (5.4% and 5.2% 
respectively). Using stockings/tights is more efficient in 
most cases, yet due to the discomfort of putting them 
on, the use of knee socks is “the lesser evil” than not 
applying compression therapy at all.
It is difficult to explain the considerable diversity 
in the frequency of using phlebotropic drugs among 
patients in different voivodeships (from 11.2 to 56.1%).
The presented differences cannot be explained by 
the variability of ChVD progression, at least the one 
reported here. It is perhaps a consequence of a different 
training system of family doctors in the field of ChVD 
treatment in respective voivodeships.
The limitations of the conducted analysis result 
from the research methodology — recruiting patients 
who did not use phlebotropic drugs in the past or 
who discontinued this therapy. Hence, the study 
did not cover patients taking phlebotropic drugs on 
a regular basis. On the other hand, this study allows 
to assess the frequency of ChVD symptoms in a more 
reliable way, as they are not disturbed by the intake 
of these drugs.
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Conclusions
There is a significant territorial diversity in Poland 
in the frequency of the reported symptoms and of the 
conservative therapy of the chronic venous disease. The 
differences in the frequency of diagnosing the respective 
stages of the chronic venous disease are most probably 
caused by the insufficient awareness of the diagnostic 
criteria of the international CEAP scale by a substantial 
number of PHC doctors.
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